Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WebMD In Web Of Intrigue; IRS, DoJ Searches Pose Untimely Distraction

Executive Summary

WebMD is facing an unexpected hurdle to its expansion plans after the Internal Revenue Service and Department of Justice raided three company facilities Sept. 3

You may also be interested in...



WebMD Thinks Big: Acquisitions, Medicare Rx May Define Role

WebMD sees the Medicare prescription drug benefit as an opportunity to define a broader role for the company in health care

Synetic Connects To 120,000 MDs; Medco Founder Wygod In Portal Race

Synetic's attempt to build a computer communication channel for doctors will get a boost from access to 120,000 doctors already using the electronic practice management system of Medical Manager Corporation.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

PS017586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel